2025-07-13 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc (TDOC) based on the provided data, presented in English with simple numbers and analysis.

## TDOC (Teladoc Health Inc) Analysis

**Company Overview:** Teladoc Health Inc. is a telehealth company providing virtual healthcare services.

### 1. Performance vs. S&P 500 (VOO)

*   **TDOC Cumulative Return:** -62.96%
*   **VOO Cumulative Return:** 96.54%
*   **Performance Difference (vs. VOO):** -158.0
*   **Relative Performance Divergence:** 0.4 (This indicates TDOC's relative underperformance compared to VOO is near the lower end of its historical range.)

**Analysis:** TDOC has significantly underperformed the S&P 500 (VOO). The large negative performance difference (-158.0) highlights this disparity. The relative performance divergence of 0.4 suggests that while the underperformance is substantial, it's within the historical context of TDOC's volatility compared to the market.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha  | Beta  | Cap(B) |
|------------|---------|-------|--------|-------|--------|
| 2015-2017  | 76.0%   | 60.6% | 50.0%  | -0.0  | 6.1    |
| 2016-2018  | 128.0%  | 59.3% | 110.0% | -0.0  | 8.7    |
| 2017-2019  | 176.0%  | 59.3% | 147.0% | 0.4   | 14.7   |
| 2018-2020  | 237.0%  | 64.0% | 217.0% | 0.1   | 35.1   |
| 2019-2021  | -83.0%  | 64.0% | -132.0% | 0.1   | 16.1   |
| 2020-2022  | -295.0% | 81.3% | -297.0% | 0.0   | 4.2    |
| 2021-2023  | -488.0% | 81.3% | -506.0% | -0.6  | 3.8    |
| 2022-2024  | -111.0% | 81.3% | -137.0% | -0.8  | 1.6    |
| 2023-2025  | -34.0%  | 72.9% | -81.0%  | -0.8  | 1.5    |

**Analysis:**

*   **CAGR:** Shows strong historical growth (2015-2020) followed by significant decline.
*   **MDD (Maximum Drawdown):** Consistently high drawdowns indicate significant volatility and risk.
*   **Alpha:** Positive alpha in earlier years suggests outperformance relative to its risk-adjusted benchmark, but recent negative alpha indicates underperformance.
*   **Beta:** Beta values close to zero or negative suggest the stock is not strongly correlated with the overall market, and in recent periods, it has moved inversely to the market (negative beta).
*   **Cap(B):** Market capitalization has decreased substantially in recent years.

### 2. Recent Stock Price Movement

*   **Current Price:** 8.32
*   **Previous Close:** 8.81
*   **Change:** -5.56%
*   **5-Day Moving Average:** 8.51
*   **20-Day Moving Average:** 7.92
*   **60-Day Moving Average:** 7.38

**Analysis:** The stock price has recently decreased (-5.56% change). The 5-day moving average is above the 20-day and 60-day moving averages, suggesting a short-term upward trend *within* a potentially longer-term downtrend as indicated by the 20-day being above the 60-day.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 65.37 (Approaching overbought territory)
*   **PPO:** 0.52
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Recent Relative Divergence Change:** 0.4 (+) Short-term increase
*   **Expected Return:** -9526.6%

**Analysis:**

*   **MRI:** Suggests low market risk, but this should be interpreted with caution considering the stock's specific volatility.
*   **RSI:** Indicates the stock is approaching overbought conditions, suggesting a potential pullback.
*   **PPO:** Positive PPO indicates that the 20-day EMA is above the 50-day EMA, suggesting the potential beginning of an upward trend.
*   **Hybrid Signal:** Cautiously suggests buying a small amount, but with a warning, likely due to the MRI but also the recent volatility.
*   **Recent Relative Divergence Change:** Suggests a short-term upward trend relative to VOO.
*   **Expected Return:** The extremely negative expected return suggests a very pessimistic outlook for long-term investment, significantly underperforming the S&P 500.

**The significant price change (-5.56%) reflects recent volatility and is crucial to consider in the overall analysis.**

### 4. Recent News & Significant Events

*   **[2025-07-11]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-10]:** Analysts discussing performance and outlook in context of industry trends.
*   **[2025-07-09]:** Notable stock volatility influenced by news, earnings, or executive actions.
*   **[2025-07-12]:** Market experts highlight risks and opportunities, advise monitoring news.

**Analysis:** The news suggests that TDOC is experiencing significant events and volatility, requiring careful monitoring of news and company announcements.

### 5. Recent Earnings Analysis

| Date       | EPS   | Revenue   |
|------------|-------|-----------|
| 2025-05-01 | -0.53 | $0.63B    |
| 2024-10-31 | -0.19 | $0.64B    |
| 2024-08-01 | -4.92 | $0.64B    |
| 2024-04-26 | -0.49 | $0.65B    |
| 2025-05-01 | -0.49 | $0.65B    |

**Analysis:** The company is consistently reporting negative EPS (Earnings Per Share), indicating losses. Revenue is relatively stable around $0.64B, but not enough to offset costs and generate profit.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $0.63B    | 68.73%        |
| 2024-12-31   | $0.64B    | 70.50%        |
| 2024-09-30   | $0.64B    | 71.94%        |
| 2024-06-30   | $0.64B    | 70.73%        |
| 2024-03-31   | $0.65B    | 69.89%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-03-31   | $1.43B    | -6.52%    |
| 2024-12-31   | $1.49B    | -3.25%    |
| 2024-09-30   | $1.51B    | -2.21%    |
| 2024-06-30   | $1.50B    | -55.77%   |
| 2024-03-31   | $2.29B    | -3.58%    |

**Analysis:**

*   **Revenue and Profitability:** While revenue is relatively stable, the profit margin remains high, suggesting that the company has a good control of expenses related to generating revenue.
*   **Capital and Profitability:** Equity is decreasing, and ROE (Return on Equity) is negative, reflecting the company's inability to generate profits from its equity.

### 7. Overall Summary

Teladoc Health Inc. (TDOC) faces significant challenges:

*   **Underperformance:** Substantially underperforming the S&P 500.
*   **Volatility:** High historical volatility and recent price fluctuations.
*   **Negative Earnings:** Consistent negative EPS and ROE indicate profitability issues.
*   **Recent Volatility:** The recent price drop of over 5% highlights ongoing market sensitivity.
*   **Financial Health:** Although profit margins remain strong, equity is decreasing.

**In conclusion, based on the provided data, TDOC appears to be a high-risk investment with significant challenges in profitability and market performance. While there might be short-term trading opportunities, long-term investment requires careful consideration of the company's ability to turn around its financial performance and market perception.**
